T 0591/22 (Missing statement of grounds/AMGEN) of 23.09.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T059122.20220923
- Date of decision
- 23 September 2022
- Case number
- T 0591/22
- Online on
- 30 September 2022
- Petition for review of
- -
- Application number
- 18175497.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- RAPID DISSOLUTION FORMULATION OF A CINACALCET HCL
- Applicant name
- Amgen Inc.
- Opponent name
- Teva Pharmaceutical Industries Ltd
HGF Limited
Gillard, Richard Edward
Glenmark Pharmaceuticals Europe Ltd
BIOGARAN
Zentiva, k.s.
MAIWALD PATENTANWALTS- UND
RECHTSANWALTSGESELLSCHAFT MBH
Aechter, Bernd
Accord Healthcare
betapharm Arzneimittel GmbH
Hexal AG - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 108European Patent Convention R 99(2)European Patent Convention R 101(1)European Patent Convention R 126(2)
- Keywords
- Admissibility of appeal - missing statement of grounds
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is rejected as inadmissible.